Lewis H. Bender

CIK: 0001238705

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INTS

INTENSITY THERAPEUTICS, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

INTS
INTENSITY THERAPEUTICS, INC.
Jul 16, 2026
Award(A)
Stock Option (right to buy Common Stock)
Direct
78K shares-
INTS
INTENSITY THERAPEUTICS, INC.
Mar 26, 2026
Award(A)
Direct
37.7K shares at avg. $6.11$231K
INTS
INTENSITY THERAPEUTICS, INC.
May 2, 2025
Award(A)
Stock Option (right to buy Common Stock)
Direct
700K shares-

		Type	Shares	Price		Ownership
Jul 16, 2026	INTS INTENSITY THERAPEUTICS, INC.	Award(A) Stock Option (right to buy Common Stock)	78,000	-	-	Direct
Mar 26, 2026	INTS INTENSITY THERAPEUTICS, INC.	Award(A)	37,749	$6.11	$230,646	Direct
May 2, 2025	INTS INTENSITY THERAPEUTICS, INC.	Award(A) Stock Option (right to buy Common Stock)	700,000	-	-	Direct

1-3 of 3 transactions

About BENDER LEWIS H

BENDER LEWIS H (SEC CIK 0001238705) files insider reports with the SEC as President and CEO of INTENSITY THERAPEUTICS, INC. (INTS).

Signal8 holds 3 ownership filings by BENDER LEWIS H, all Form 4s, filed between May 6, 2025 and Jul 20, 2026. Those filings report 3 transactions, from May 2, 2025 to Jul 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on BENDER LEWIS H's filings is in SHELTON, CT.

Recent filings by BENDER LEWIS H

Jul 16, 2026: Grant or award of INTS derivative securities (Form 4, code A).
Mar 26, 2026: Grant or award of INTS shares (Form 4, code A).
May 2, 2025: Grant or award of INTS derivative securities (Form 4, code A).

Other insiders filing for INTENSITY THERAPEUTICS, INC. (INTS)

DUBIN THOMAS I H, Director
Donovan Daniel, Director
GOLDBERG MARK A, Director
Leahy Emer, Director
Wesolowski John M, Principal Accounting Officer
Talamo Joseph, Chief Financial Officer

How to read Form 4 transaction codes